BindingDB logo
myBDB logout

Patent code US10570140

Compile Data Set for Download or QSAR
Found 42 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435525
PNG
((2R,3S,4R,5R)-2-(((2-amino-3- bromoquinolin-7-yl)o...)
Show SMILES C[C@@]1(O)[C@@H](COc2ccc3cc(Br)c(N)nc3c2)O[C@H]([C@@H]1O)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C21H21BrN6O4/c1-21(30)15(8-31-11-3-2-10-6-13(22)18(24)27-14(10)7-11)32-20(16(21)29)28-5-4-12-17(23)25-9-26-19(12)28/h2-7,9,15-16,20,29-30H,8H2,1H3,(H2,24,27)(H2,23,25,26)/t15-,16+,20-,21-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 0.5n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435509
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES C[C@@]1(O)[C@@H](COc2ccc3ccc(N)nc3c2)O[C@H]([C@@H]1O)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C21H22N6O4/c1-21(29)15(9-30-12-4-2-11-3-5-16(22)26-14(11)8-12)31-20(17(21)28)27-7-6-13-18(23)24-10-25-19(13)27/h2-8,10,15,17,20,28-29H,9H2,1H3,(H2,22,26)(H2,23,24,25)/t15-,17+,20-,21-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 0.75n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435657
PNG
((2R,3S,4R,5R)-2-(((2-amino-3- bromoquinolin-7-yl)o...)
Show SMILES Cc1ncnc2n(ccc12)[C@@H]1O[C@H](COc2ccc3cc(Br)c(N)nc3c2)[C@@](C)(O)[C@H]1O
Show InChI InChI=1S/C22H22BrN5O4/c1-11-14-5-6-28(20(14)26-10-25-11)21-18(29)22(2,30)17(32-21)9-31-13-4-3-12-7-15(23)19(24)27-16(12)8-13/h3-8,10,17-18,21,29-30H,9H2,1-2H3,(H2,24,27)/t17-,18+,21-,22-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 0.800n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435523
PNG
((2R,3S,4R,5R)-5-(4-amino-5-fluoro-7H- pyrrolo[2,3-...)
Show SMILES C[C@@]1(O)[C@@H](COc2ccc3ccc(N)nc3c2)O[C@H]([C@@H]1O)n1cc(F)c2c(N)ncnc12
Show InChI InChI=1S/C21H21FN6O4/c1-21(30)14(8-31-11-4-2-10-3-5-15(23)27-13(10)6-11)32-20(17(21)29)28-7-12(22)16-18(24)25-9-26-19(16)28/h2-7,9,14,17,20,29-30H,8H2,1H3,(H2,23,27)(H2,24,25,26)/t14-,17+,20-,21-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 0.850n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435710
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES Cc1cnc2cc(OC[C@H]3O[C@H]([C@H](O)[C@]3(C)O)n3ccc4c(N)ncnc34)ccn12
Show InChI InChI=1S/C20H22N6O4/c1-11-8-22-15-7-12(3-5-25(11)15)29-9-14-20(2,28)16(27)19(30-14)26-6-4-13-17(21)23-10-24-18(13)26/h3-8,10,14,16,19,27-28H,9H2,1-2H3,(H2,21,23,24)/t14-,16+,19-,20-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 0.900n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435709
PNG
((2R,3S,4R,5R)-3-methyl-5-(4-methyl-7H- pyrrolo[2,3...)
Show SMILES Cc1cnc2cc(OC[C@H]3O[C@H]([C@H](O)[C@]3(C)O)n3ccc4c(C)ncnc34)ccn12
Show InChI InChI=1S/C21H23N5O4/c1-12-9-22-17-8-14(4-6-25(12)17)29-10-16-21(3,28)18(27)20(30-16)26-7-5-15-13(2)23-11-24-19(15)26/h4-9,11,16,18,20,27-28H,10H2,1-3H3/t16-,18+,20-,21-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 1n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435524
PNG
((2R,3S,4R,5R)-2-(((2-aminoquinolin-7- yl)oxy)methy...)
Show SMILES Cc1ncnc2n(ccc12)[C@@H]1O[C@H](COc2ccc3ccc(N)nc3c2)[C@@](C)(O)[C@H]1O
Show InChI InChI=1S/C22H23N5O4/c1-12-15-7-8-27(20(15)25-11-24-12)21-19(28)22(2,29)17(31-21)10-30-14-5-3-13-4-6-18(23)26-16(13)9-14/h3-9,11,17,19,21,28-29H,10H2,1-2H3,(H2,23,26)/t17-,19+,21-,22-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 1.10n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435651
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES C[C@]1(O)[C@@H](O)[C@@H](O[C@@H]1[C@H](O)c1ccc(Cl)c(Cl)c1)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C18H18Cl2N4O4/c1-18(27)13(26)17(24-5-4-9-15(21)22-7-23-16(9)24)28-14(18)12(25)8-2-3-10(19)11(20)6-8/h2-7,12-14,17,25-27H,1H3,(H2,21,22,23)/t12-,13+,14-,17-,18+/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 1.5n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435518
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES Nc1ccc2ccc(OC[C@H]3O[C@H]([C@H](O)[C@@]3(O)C#C)n3ccc4c(N)ncnc34)cc2n1
Show InChI InChI=1S/C22H20N6O4/c1-2-22(30)16(10-31-13-5-3-12-4-6-17(23)27-15(12)9-13)32-21(18(22)29)28-8-7-14-19(24)25-11-26-20(14)28/h1,3-9,11,16,18,21,29-30H,10H2,(H2,23,27)(H2,24,25,26)/t16-,18+,21-,22-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 1.60n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435516
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES Nc1ccc2ccc(OC[C@H]3O[C@H]([C@H](O)[C@@]3(O)C(F)(F)F)n3ccc4c(N)ncnc34)cc2n1
Show InChI InChI=1S/C21H19F3N6O4/c22-21(23,24)20(32)14(8-33-11-3-1-10-2-4-15(25)29-13(10)7-11)34-19(16(20)31)30-6-5-12-17(26)27-9-28-18(12)30/h1-7,9,14,16,19,31-32H,8H2,(H2,25,29)(H2,26,27,28)/t14-,16+,19-,20-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 1.90n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435705
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES C[C@]1(O)[C@@H](O)[C@@H](O[C@@H]1[C@H](O)c1ccc(F)c(c1)C(F)(F)F)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C19H18F4N4O4/c1-18(30)13(29)17(27-5-4-9-15(24)25-7-26-16(9)27)31-14(18)12(28)8-2-3-11(20)10(6-8)19(21,22)23/h2-7,12-14,17,28-30H,1H3,(H2,24,25,26)/t12-,13+,14-,17-,18+/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 3n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435560
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES C[C@]1(O)[C@@H](O)[C@@H](O[C@@H]1[C@H](O)c1ccc(Cl)cc1)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C18H19ClN4O4/c1-18(26)13(25)17(23-7-6-11-15(20)21-8-22-16(11)23)27-14(18)12(24)9-2-4-10(19)5-3-9/h2-8,12-14,17,24-26H,1H3,(H2,20,21,22)/t12-,13+,14-,17-,18+/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 4.80n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435655
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES C[C@@]1(O)[C@@H](COc2ccc3cccnc3c2)O[C@H]([C@@H]1O)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C21H21N5O4/c1-21(28)16(10-29-13-5-4-12-3-2-7-23-15(12)9-13)30-20(17(21)27)26-8-6-14-18(22)24-11-25-19(14)26/h2-9,11,16-17,20,27-28H,10H2,1H3,(H2,22,24,25)/t16-,17+,20-,21-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 5.80n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435704
PNG
((2R,3S,4R,5R)-2-((R)-hydroxy(4- (trifluoromethyl)p...)
Show SMILES Cc1ncnc2n(ccc12)[C@@H]1O[C@H]([C@H](O)c2ccc(cc2)C(F)(F)F)[C@@](C)(O)[C@H]1O
Show InChI InChI=1S/C20H20F3N3O4/c1-10-13-7-8-26(17(13)25-9-24-10)18-15(28)19(2,29)16(30-18)14(27)11-3-5-12(6-4-11)20(21,22)23/h3-9,14-16,18,27-29H,1-2H3/t14-,15+,16-,18-,19+/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 7n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435520
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES Nc1ccc2ccc(OC[C@H]3O[C@H]([C@H](O)[C@@]3(O)C=C)n3ccc4c(N)ncnc34)cc2n1
Show InChI InChI=1S/C22H22N6O4/c1-2-22(30)16(10-31-13-5-3-12-4-6-17(23)27-15(12)9-13)32-21(18(22)29)28-8-7-14-19(24)25-11-26-20(14)28/h2-9,11,16,18,21,29-30H,1,10H2,(H2,23,27)(H2,24,25,26)/t16-,18+,21-,22-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 8.70n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435571
PNG
(7-((2R,3R,4S,5R)-5-(((2-aminoquinolin-7- yl)oxy)me...)
Show SMILES CO\N=C1/NC=NC2C1C=CN2[C@@H]1O[C@H](COc2ccc3ccc(N)nc3c2)[C@@](C)(O)[C@H]1O
Show InChI InChI=1S/C22H26N6O5/c1-22(30)16(10-32-13-5-3-12-4-6-17(23)26-15(12)9-13)33-21(18(22)29)28-8-7-14-19(27-31-2)24-11-25-20(14)28/h3-9,11,14,16,18,20-21,29-30H,10H2,1-2H3,(H2,23,26)(H,24,25,27)/t14?,16-,18+,20?,21-,22-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 10n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435659
PNG
((2R,3S,4R,5R)-2-((R)-(4-chloro-3- methylphenyl)(hy...)
Show SMILES Cc1cc(ccc1Cl)[C@@H](O)[C@H]1O[C@H]([C@H](O)[C@]1(C)O)n1ccc2c(C)ncnc12
Show InChI InChI=1S/C20H22ClN3O4/c1-10-8-12(4-5-14(10)21)15(25)17-20(3,27)16(26)19(28-17)24-7-6-13-11(2)22-9-23-18(13)24/h4-9,15-17,19,25-27H,1-3H3/t15-,16+,17-,19-,20+/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 11n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435700
PNG
((2R,3S,4R,5R)-2-((R)-(3,4- dichlorophenyl)(hydroxy...)
Show SMILES Cc1ncnc2n(ccc12)[C@@H]1O[C@H]([C@H](O)c2ccc(Cl)c(Cl)c2)[C@@](C)(O)[C@H]1O
Show InChI InChI=1S/C19H19Cl2N3O4/c1-9-11-5-6-24(17(11)23-8-22-9)18-15(26)19(2,27)16(28-18)14(25)10-3-4-12(20)13(21)7-10/h3-8,14-16,18,25-27H,1-2H3/t14-,15+,16-,18-,19+/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 11n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435703
PNG
((2R,3S,4R,5R)-2-((R)-(4-fluoro-3- (trifluorometh- ...)
Show SMILES Cc1ncnc2n(ccc12)[C@@H]1O[C@H]([C@H](O)c2ccc(F)c(c2)C(F)(F)F)[C@@](C)(O)[C@H]1O
Show InChI InChI=1S/C20H19F4N3O4/c1-9-11-5-6-27(17(11)26-8-25-9)18-15(29)19(2,30)16(31-18)14(28)10-3-4-13(21)12(7-10)20(22,23)24/h3-8,14-16,18,28-30H,1-2H3/t14-,15+,16-,18-,19+/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 16n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435653
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES C[C@@]1(O)[C@@H](Cc2ccc(Cl)c(Cl)c2)O[C@H]([C@@H]1O)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C18H18Cl2N4O3/c1-18(26)13(7-9-2-3-11(19)12(20)6-9)27-17(14(18)25)24-5-4-10-15(21)22-8-23-16(10)24/h2-6,8,13-14,17,25-26H,7H2,1H3,(H2,21,22,23)/t13-,14+,17-,18-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 17n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435658
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES Cc1cc(ccc1Cl)[C@@H](O)[C@H]1O[C@H]([C@H](O)[C@]1(C)O)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C19H21ClN4O4/c1-9-7-10(3-4-12(9)20)13(25)15-19(2,27)14(26)18(28-15)24-6-5-11-16(21)22-8-23-17(11)24/h3-8,13-15,18,25-27H,1-2H3,(H2,21,22,23)/t13-,14+,15-,18-,19+/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 68n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435650
PNG
((Z)-7-((2R,3R,4S,5R)-5-((R)-(4- chlorophenyl)(hydr...)
Show SMILES CC1(C)[C@@H](O)[C@@H](OC1[C@H](O)c1ccc(Cl)cc1)c1ccc2c1nc[nH]\c2=N/O
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 92n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435541
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES C[C@@]1(O)[C@@H](COc2cccc(CN)c2)O[C@H]([C@@H]1O)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C19H23N5O4/c1-19(26)14(9-27-12-4-2-3-11(7-12)8-20)28-18(15(19)25)24-6-5-13-16(21)22-10-23-17(13)24/h2-7,10,14-15,18,25-26H,8-9,20H2,1H3,(H2,21,22,23)/t14-,15+,18-,19-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 126n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435656
PNG
((2R,3S,4R,5R)-3-methyl-5-(4-methyl-7H- pyrrolo[2,3...)
Show SMILES Cc1ncnc2n(ccc12)[C@@H]1O[C@H](COc2ccc3cccnc3c2)[C@@](C)(O)[C@H]1O
Show InChI InChI=1S/C22H22N4O4/c1-13-16-7-9-26(20(16)25-12-24-13)21-19(27)22(2,28)18(30-21)11-29-15-6-5-14-4-3-8-23-17(14)10-15/h3-10,12,18-19,21,27-28H,11H2,1-2H3/t18-,19+,21-,22-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 198n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435652
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES C[C@@]1(O)[C@@H](Cc2ccc3OCOc3c2)O[C@H]([C@@H]1O)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C19H20N4O5/c1-19(25)14(7-10-2-3-12-13(6-10)27-9-26-12)28-18(15(19)24)23-5-4-11-16(20)21-8-22-17(11)23/h2-6,8,14-15,18,24-25H,7,9H2,1H3,(H2,20,21,22)/t14-,15+,18-,19-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 229n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435702
PNG
((2R,3S,4R,5R)-2-((R)-hydroxy(4- (trifluoromethoxy)...)
Show SMILES Cc1ncnc2n(ccc12)[C@@H]1O[C@H]([C@H](O)c2ccc(OC(F)(F)F)cc2)[C@@](C)(O)[C@H]1O
Show InChI InChI=1S/C20H20F3N3O5/c1-10-13-7-8-26(17(13)25-9-24-10)18-15(28)19(2,29)16(30-18)14(27)11-3-5-12(6-4-11)31-20(21,22)23/h3-9,14-16,18,27-29H,1-2H3/t14-,15+,16-,18-,19+/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 368n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435701
PNG
((2R,3S,4R,5R)-2-((R)-hydroxy(4- isopropylphenyl)me...)
Show SMILES CC(C)c1ccc(cc1)[C@@H](O)[C@H]1O[C@H]([C@H](O)[C@]1(C)O)n1ccc2c(C)ncnc12
Show InChI InChI=1S/C22H27N3O4/c1-12(2)14-5-7-15(8-6-14)17(26)19-22(4,28)18(27)21(29-19)25-10-9-16-13(3)23-11-24-20(16)25/h5-12,17-19,21,26-28H,1-4H3/t17-,18+,19-,21-,22+/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 399n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435654
PNG
((2R,3S,4R,5R)-2-(3,4-dichlorobenzyl)-3- methyl-5-(...)
Show SMILES C[C@@]1(O)[C@@H](Cc2ccc(Cl)c(Cl)c2)O[C@H]([C@@H]1O)n1ccc2cncnc12
Show InChI InChI=1S/C18H17Cl2N3O3/c1-18(25)14(7-10-2-3-12(19)13(20)6-10)26-17(15(18)24)23-5-4-11-8-21-9-22-16(11)23/h2-6,8-9,14-15,17,24-25H,7H2,1H3/t14-,15+,17-,18-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 404n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435707
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES C[C@@]1(O)[C@@H](Cc2ccc(Cl)cc2CO)O[C@H]([C@@H]1O)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C19H21ClN4O4/c1-19(27)14(7-10-2-3-12(20)6-11(10)8-25)28-18(15(19)26)24-5-4-13-16(21)22-9-23-17(13)24/h2-6,9,14-15,18,25-27H,7-8H2,1H3,(H2,21,22,23)/t14-,15+,18-,19-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 413n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435572
PNG
(7-((2R,3R,4S,5R)-5-((R)-(3,4- dichlorophenyl)(hydr...)
Show SMILES CO\N=c1\nc[nH]c2n(ccc12)[C@@H]1O[C@H]([C@H](O)c2ccc(Cl)c(Cl)c2)[C@@](C)(O)[C@H]1O
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 428n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435708
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES C[C@]1(O)[C@@H](O)[C@@H](OC1[C@@H](O)c1ccc(Cl)c(Cl)c1)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C18H18Cl2N4O4/c1-18(27)13(26)17(24-5-4-9-15(21)22-7-23-16(9)24)28-14(18)12(25)8-2-3-10(19)11(20)6-8/h2-7,12-14,17,25-27H,1H3,(H2,21,22,23)/t12-,13-,14?,17+,18-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 707n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435617
PNG
((2S,3S,4R,5R)-5-(4-amino-7H-pyrrolo[2,3- d]pyrimid...)
Show SMILES C[C@]1(O)[C@@H](O)[C@@H](O[C@@H]1C(=O)Nc1cccc(CN)c1)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C19H22N6O4/c1-19(28)13(26)18(25-6-5-12-15(21)22-9-23-16(12)25)29-14(19)17(27)24-11-4-2-3-10(7-11)8-20/h2-7,9,13-14,18,26,28H,8,20H2,1H3,(H,24,27)(H2,21,22,23)/t13-,14+,18+,19-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 825n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435526
PNG
((2S,3S,4R,5R)-5-(4-amino-7H-pyrrolo[2,3- d]pyrimid...)
Show SMILES CSC[C@H]1O[C@H]([C@H](O)[C@]1(C)O)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C13H18N4O3S/c1-13(19)8(5-21-2)20-12(9(13)18)17-4-3-7-10(14)15-6-16-11(7)17/h3-4,6,8-9,12,18-19H,5H2,1-2H3,(H2,14,15,16)/t8-,9+,12-,13-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 900n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435532
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES COC[C@H]1O[C@H]([C@H](O)[C@]1(C)O)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C13H18N4O4/c1-13(19)8(5-20-2)21-12(9(13)18)17-4-3-7-10(14)15-6-16-11(7)17/h3-4,6,8-9,12,18-19H,5H2,1-2H3,(H2,14,15,16)/t8-,9+,12-,13-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 1.44E+3n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435706
PNG
((2R,3S,4R,5R)-2-(4-chloro-2- (hydroxymethyl)benzyl...)
Show SMILES Cc1ncnc2n(ccc12)[C@@H]1O[C@H](Cc2ccc(Cl)cc2CO)[C@@](C)(O)[C@H]1O
Show InChI InChI=1S/C20H22ClN3O4/c1-11-15-5-6-24(18(15)23-10-22-11)19-17(26)20(2,27)16(28-19)8-12-3-4-14(21)7-13(12)9-25/h3-7,10,16-17,19,25-27H,8-9H2,1-2H3/t16-,17+,19-,20-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 1.61E+3n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435619
PNG
((Z)-7-((2R,3R,4S,5R)-5-((R)-(4- chlorophenyl)(hydr...)
Show SMILES CO\N=c1/[nH]cnc2n(ccc12)[C@@H]1O[C@H]([C@H](O)c2ccc(Cl)cc2)[C@@](C)(O)[C@H]1O
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 3.48E+3n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435540
PNG
(1-(3-(((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]...)
Show SMILES C[C@@]1(O)[C@@H](COc2cccc(NC(N)=O)c2)O[C@H]([C@@H]1O)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C19H22N6O5/c1-19(28)13(8-29-11-4-2-3-10(7-11)24-18(21)27)30-17(14(19)26)25-6-5-12-15(20)22-9-23-16(12)25/h2-7,9,13-14,17,26,28H,8H2,1H3,(H2,20,22,23)(H3,21,24,27)/t13-,14+,17-,19-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 7.84E+3n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435608
PNG
((2S,3S,4R,5R)-N-(3- (aminomethyl)phenyl)-5-(4-chlo...)
Show SMILES C[C@]1(O)[C@@H](O)[C@@H](O[C@@H]1C(=O)Nc1cccc(CN)c1)n1ccc2c(Cl)ncnc12
Show InChI InChI=1S/C19H20ClN5O4/c1-19(28)13(26)18(25-6-5-12-15(20)22-9-23-16(12)25)29-14(19)17(27)24-11-4-2-3-10(7-11)8-21/h2-7,9,13-14,18,26,28H,8,21H2,1H3,(H,24,27)/t13-,14+,18+,19-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 9.10E+3n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435630
PNG
((Z)-7-((2R,3R,4S,5R)-3,4-dihydroxy-5- (((2-(methox...)
Show SMILES CONc1ccc2ccc(OC[C@H]3O[C@H]([C@H](O)[C@]3(C)O)n3ccc4c3nc[nH]\c4=N/OC)cc2n1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 1.15E+4n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435601
PNG
((2S,3S,4R,5R)-3-methyl-5-(4- (methylamino)-7H-pyrr...)
Show SMILES CNc1ncnc2n(ccc12)[C@@H]1O[C@H](CSC)[C@@](C)(O)[C@H]1O
Show InChI InChI=1S/C14H20N4O3S/c1-14(20)9(6-22-3)21-13(10(14)19)18-5-4-8-11(15-2)16-7-17-12(8)18/h4-5,7,9-10,13,19-20H,6H2,1-3H3,(H,15,16,17)/t9-,10+,13-,14-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 1.41E+4n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435533
PNG
((2R,3S,4R,5R)-5-(4-amino-7H- pyrrolo[2,3-d]pyrimid...)
Show SMILES C[C@@]1(O)[C@@H](COc2ccccc2)O[C@H]([C@@H]1O)n1ccc2c(N)ncnc12
Show InChI InChI=1S/C18H20N4O4/c1-18(24)13(9-25-11-5-3-2-4-6-11)26-17(14(18)23)22-8-7-12-15(19)20-10-21-16(12)22/h2-8,10,13-14,17,23-24H,9H2,1H3,(H2,19,20,21)/t13-,14+,17-,18-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 1.43E+4n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
PRMT5/MEP50 Enzyme


(Homo sapiens (Human))
BDBM435602
PNG
(1-(3-(((2R,3S,4R,5R)-5-(4-chloro-7H- pyrrolo[2,3-d...)
Show SMILES C[C@@]1(O)[C@@H](COc2cccc(NC(N)=O)c2)O[C@H]([C@@H]1O)n1ccc2c(Cl)ncnc12
Show InChI InChI=1S/C19H20ClN5O5/c1-19(28)13(8-29-11-4-2-3-10(7-11)24-18(21)27)30-17(14(19)26)25-6-5-12-15(20)22-9-23-16(12)25/h2-7,9,13-14,17,26,28H,8H2,1H3,(H3,21,24,27)/t13-,14+,17-,19-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a 2.00E+5n/an/an/an/an/an/a



Prelude Therapeutics Incorporated

US Patent


Assay Description
Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (50 mM Tris-HCl, pH 8.5,...


US Patent US10570140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1GTT
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%